Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Insys Therapeutics Inc

+ Add to Watchlist

INSY:US

61.6101 USD 1.1701 1.94%

As of 10:20:19 ET on 04/21/2015.

Snapshot for Insys Therapeutics Inc (INSY)

Open: 60.8200 Day's Range: 60.2500 - 61.9500 Volume: 67,157
Previous Close: 60.4400 52wk Range: 20.5200 - 62.4800 1-Yr Rtn: +55.99%

Stock Chart for INSY

No chart data available.
  • INSY:US 61.8334
  • 1D
  • 1M
  • 1Y
60.4400
Interactive INSY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSY

Current P/E Ratio (ttm) 58.6796
Estimated P/E(12/2015) 36.1267
Relative P/E vs. SPX 3.2344
Earnings Per Share (USD) (ttm) 1.0300
Est. EPS (USD) (12/2015) 1.6730
Est. PEG Ratio 1.4167
Market Cap (M USD) 2,155.82
Shares Outstanding (M) 35.67
30 Day Average Volume 354,178
Price/Book (mrq) 13.1778
Price/Sale (ttm) 9.5800
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INSY

Insys Therapeutics, Inc. develops cancer support drugs. The Company's support care candidates include a fast-acting sublingual spray for cancer pain, and a dronabinol product used to treat chemotherapy-induced nausea and vomiting and to stimulate appetite in AIDS patients.

John N KapoorChairmanMichael L BabichPresident/CEO
Darryl S BakerChief Financial OfficerFranc E Del Fosse IIISecretary/General Counsel
More Company Profile & Key Executives for INSY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil